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Background and purpose   After total hip arthroplasty, disloca-
tions are a frequent complication and are difficult to treat in some 
patients. A great variety of implants and antiluxation mechanisms 
are used in surgical therapy.
Methods      8  patients  had  9  Duraloc  Constrained  Inlays 
implanted  at  our  clinic  between  October  2003  and  November 
2006, for recurrent dislocations. A retrospective follow-up study 
was carried out.
Results   All patients suffered a failure of the expanding ring, 
the metal ring being squeezed out of the polyethylene notch. The 
mechanism of failure can be explained by impingement due to 
the implant design. At the time of writing, 3 patients have had to 
undergo revision surgery.
Interpretation      The  Duraloc  Constrained  Inlay  has  shown 
unacceptably high failure rates.  

The Duraloc Constrained Inlay is one of many methods used 
for revision of recurrent dislocations after total hip arthroplasty. 
In our department, this inlay was implanted from October 
2003 through November 2006 for recurrent dislocations.
After 2 patients had had to be revised because of inlay fail-
ure within just a few months in 2007, all patients treated with 
this inlay at our department were called in for a retrospective 
follow-up in order to check for further cases of failure in this 
group of patients, who were considered to be at potentially 
high risk.
Patients and methods
The patients were identified with the help of the regional Tyro-
lean Arthroplasty Register, as well as by means of the in-house 
operation  documentation  and  the  manufacturer’s  delivery 
documents. The complete medical histories of the patients, as 
far as they were associated with arthroplasty treatment, were 
analyzed in retrospect.
8  patients  had  been  treated  with  9  Duraloc  Constrained 
Inlays: in 1 patient a failing Duraloc inlay had been revised 
by replacing it with the same system (Table). On average, 4.4 
(2–10) incidents had occurred before implantation of the inlay. 
The period between primary and revision surgery averaged 20 
(1–72) months. 
Excluding the 2 patients who had been revised (cases no. 2 
and 4), the average time interval between implantation and the 
follow-up examination was 19 (9–47) months. 7 patients (8 
hips) had clinical and radiographic follow-up. 1 patient could 
be reached by phone, but he declined to be examined. 
3
Data on 7 patients treated with the Duraloc Constrained Inlay because of recurrent dislocation
Patient  Stem  Cup size  Number of  Number of operations  Clinical outcome  Revision   Reason for  
no.      dislocations  prior to implantation of the    surgery  revision   
        Duraloc Constrained Inlay   
1  Accolade (Stryker)  54  3  2  Ring dislocated  No 
2  CBC (Mathys)  52  2  3  2 revisions due to    Yes  Recurrent      
          dislocation    dislocation (twice)
          on the same hip     
3  CBC (Mathys)  54  5  2  Ring dislocated  No 
4  ABG( Stryker)  54  > 6  4  Revision  Yes  Fracture, metallosis
5  CBC (Mathys)  60  > 3  3  Ring dislocated  No 
6  SP II (Link)  54  3  2  Revision  Yes  Aseptic stem loosening 
7  CBC (Mathys)  54  2  2  Ring dislocated  No 546  Acta Orthopaedica 2009; 80 (5): 545–547
Results
Implant failure was detected in all patients 
who  had  been  treated  with  the  Duraloc 
Constrained  Inlay  because  of  recurrent 
dislocation  (Table).  Either  revision  sur-
gery with an exchange of the cup implant 
had already been carried out (3 patients), 
or the expanding ring was dislocated (5 
patients).
1 patient (case no. 2) underwent revi-
sion surgery due to failure of the antilux-
ation inlay 3 years after implantation. At 
revision surgery, the same type of inlay 
was  used  again. After  1  more  year  and 
another  event  of  dislocation,  this  inlay 
was replaced with a Ganz cup and a Muel-
ler antiluxation inlay. He used a brace for 
6 weeks after surgery and no further dislo-
cations had occurred a the latest follow-up 
2 years after the intervention (Figure 1).
1 patient (case no. 4), after change to the 
Durolac Constrained Inlay 7 years after 
primary hip arthroplasty, had to undergo 
another revision surgery after 10 months 
due to a periprosthetic fracture in the area 
of the major trochanter. Surgery revealed 
an intense metallosis resulting from con-
tact of the dislocated expanding ring with 
the neck of the stem. Signs of rubbing and 
also polished spots on the titanium body 
of the neck were detected (Figures 2 and 
3).
1 patient (case no. 6) had revision sur-
gery due to stem loosening. The expanding 
ring was dislocated. The cup was revised 
too,  changing  the  system  to  a  Mueller 
antiluxation inlay. Shortly after this inter-
vention, another dislocation occurred.
In 4 patients (cases no. 1, 3, 5, and 7) 
the  follow-up  examination  revealed  a 
luxation  of  the  expanding  ring.  These 
patients reported no further dislocations 
Discussion
Our results are in line with the results of other studies, which 
have shown a high failure rate of the Duraloc Constrained Inlay 
(Della Valle et al. 2005, Williams et al. 2007). These publica-
tions focused on revision surgery as the main endpoint and 
did not present any specific information about patients with-
out symptoms of implant failure. In our series, 4 of 8 patients 
treated with this product showed no clinical symptoms apart 
from restricted hip motion, but there was evidence of disloca-
tion of the expanding ring—leading to revision surgery due to 
Figure 2. Case no. 4 before revision surgery.
Figure 1. Case no. 2: implant failure and dislocation of the second Duraloc Constrained Inlay.
and had no pain. However, they had limited mobility, which 
they regarded as an acceptable restriction to their quality of 
life considering that they had remained free of dislocations. 
1 patient did not consent to a follow-up examination. At 
a phone interview, he expressed his dissatisfaction with the 
outcome because of subluxation symptoms and restrictions 
to movement. He did not mention any inpatient treatment or 
dislocations.
Radiographs from any of the cases did not reveal any signs 
of loosening of the Durolac cups or migration of the inlays 
regarding their fixation in the cup. Acta Orthopaedica 2009; 80 (5): 545–547  547
metallosis in 1 patient. The limited mobility after implantation 
may be explained by design-induced restrictions of motion 
within the implant.
The failure mechanism could conceivably be an impinge-
ment between the elevated edge of the inlay and the neck 
of the stem, which might finally squeeze out the expanding 
ring. In the Duraloc Constrained Inlay with a metal ring any 
damage of the elevated edge, which essentially accounts for 
the protective effect against dislocation, can be disclosed radi-
olographically. This does not always apply to implants made 
entirely of polyethylene; in such cases a normal radiograph 
cannot be regarded as a safe indicator of an undamaged edge 
of the implant and proper functioning.
It is noticeable that publications about implants with a simi-
lar basic philosophy as the Duraloc Constrained Inlay have 
also  described  implant  failure,  at  least  in  individual  cases 
(Kaper and Bernini 1998, Shapiro et al. 2003, Della Valle et 
al. 2005, Guyen et al 2007, Kapoor et al 2007, Williams et al. 
2007). In the surgical therapy of recurrent dislocation, we now 
prefer the use of large head implants. 
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Figure 3. Case no. 4: intraoperatively, with defects at the neck of the 
stem.